Compare RANI & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | CMCM |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.9M | 88.8M |
| IPO Year | 2021 | 2014 |
| Metric | RANI | CMCM |
|---|---|---|
| Price | $0.84 | $3.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 658.7K | 4.9K |
| Earning Date | 05-07-2026 | 06-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,633,000.00 | N/A |
| Revenue This Year | $274.77 | $11.61 |
| Revenue Next Year | $79.44 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 58.85 | N/A |
| 52 Week Low | $0.45 | $2.65 |
| 52 Week High | $3.87 | $9.44 |
| Indicator | RANI | CMCM |
|---|---|---|
| Relative Strength Index (RSI) | 50.82 | 62.31 |
| Support Level | $0.83 | $3.32 |
| Resistance Level | $0.92 | $7.09 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 11.23 | 98.33 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The companies products and services includes Robotic Products, Global to B Services etc. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC.